KCNMB3 encodes the regulatory beta3 subunit of large conductance calcium-activated potassium (BK) channels, which modulates the functional properties of the KCNMA1 channel 1. The gene produces multiple splice variants (beta3a-d) with distinct functional properties, where some variants induce channel inactivation while others do not 1. Specifically, beta3b variants can produce rapid inactivation (approximately 2-6 ms) and right-shift voltage-dependence of activation 1. KCNMB3 expression is found in various tissues including osteoblasts, where it contributes to cell proliferation and mineralization 2. The gene shows significant disease relevance, particularly in epilepsy. A truncation mutation (delA750) is significantly associated with idiopathic generalized epilepsy, especially absence seizures, with increased frequency in patients (7.9%) compared to controls (5.5%) 3. Additionally, KCNMB3 variants interact with dietary polyunsaturated fatty acids to modulate insulin resistance 4. The gene also shows potential involvement in platelet secretion defects 5. Notably, KCNMB3 exhibits significant species differences, with mouse and human variants sharing only 62.8% amino acid identity, and some variants appearing to be primate-specific 6.